Trafficking of activated cytotoxic T lymphocytes into the central nervous system: use of a transgenic model
- PMID: 8360331
- PMCID: PMC7119476
- DOI: 10.1016/0165-5728(93)90230-v
Trafficking of activated cytotoxic T lymphocytes into the central nervous system: use of a transgenic model
Abstract
We have used cell or tissue-specific promoters to express lymphocytic choriomeningitis virus (LCMV) proteins in selected cells in independent lines of transgenic mice. Upon adoptive transfers into these mice, MHC-restricted LCMV-specific cytotoxic T lymphocytes homed specifically to either the choroid plexus (SV40 promoter) or beta cells of the islets of Langerhans (rat insulin promoter). The availability of promoters specific for neurons, oligodendrocytes and astrocytes makes this approach compelling for evaluating T cell trafficking into the CNS and for analyzing antigen presentation in vivo in the CNS.
References
-
- Campbell I.L., Oldstone M.B.A., Mucke L. Society for Neuroscience; Anaheim, CA: 1992. Neurologic disease induced in transgenic mice by the astrocyte-specific expression of interleukin-6. October 25–30.
-
- Dutko F.J., Oldstone M.B.A. Genomic and biological variation among commonly used lymphocytic choriomeningitis virus strains. J. Gen. Virol. 1983;64:1689–1689. - PubMed
-
- Falk K., Rotzscke O., Stevanovie S. Allele-specific motifs rrevealed by sequncing of self-peptides eluted from MHC molecules. Nature. 1991;351:290–296. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
